Advertisement
Screener

Lantheus Holdings, Inc. (LNTH) Increase (Decrease) in Other Noncurrent Liabilities

2.8 / 5 stars · 68/120 Roast Me

Lantheus Holdings, Inc. Increase (Decrease) in Other Noncurrent Liabilities

Lantheus Holdings, Inc. (LNTH) reported Increase (Decrease) in Other Noncurrent Liabilities of $687.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2026-08-06

  • Lantheus Holdings, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2026-06-30 was $603.00K.
  • Lantheus Holdings, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2026-03-31 was $84.00K, a 86.85% decline year-over-year.
  • Lantheus Holdings, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-12-31 was $3.00M, a 14.64% increase year-over-year.
  • Lantheus Holdings, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-09-30 was -$2.75M, a 366.83% decline year-over-year.
  • Lantheus Holdings, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2025 was $246.00K, a 95.30% decline from fiscal 2024.
  • Lantheus Holdings, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2024 was $5.24M.
  • Lantheus Holdings, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2023 was -$3.10M.
  • Lantheus Holdings, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2022 was -$12.48M.
Period endIncrease (Decrease) in Other Noncurrent Liabilities 3 monthIncrease (Decrease) in Other Noncurrent Liabilities 6 monthIncrease (Decrease) in Other Noncurrent Liabilities 9 monthIncrease (Decrease) in Other Noncurrent Liabilities 12 month
2026-06-30$603.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$687.00K
10-Q · filed 2026-08-06
$3.69M
derived: sum of 3 quarters · filed 2026-08-06
$936.00K
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$84.00K
10-Q · filed 2026-05-07
$3.08M
derived: sum of 2 quarters · filed 2026-05-07
$333.00K
derived: sum of 3 quarters · filed 2026-05-07
-$309.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$3.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$249.00K
derived: sum of 2 quarters · filed 2026-02-26
-$393.00K
derived: sum of 3 quarters · filed 2026-08-06
$246.00K
10-K · filed 2026-02-26
2025-09-30-$2.75M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$3.39M
derived: sum of 2 quarters · filed 2026-08-06
-$2.75M
10-Q · filed 2025-11-06
-$137.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30-$642.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$3.00K
10-Q · filed 2026-08-06
$2.61M
derived: sum of 3 quarters · filed 2026-08-06
$3.65M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$639.00K
10-Q · filed 2026-05-07
$3.26M
derived: sum of 2 quarters · filed 2026-05-07
$4.29M
derived: sum of 3 quarters · filed 2026-05-07
$5.44M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$2.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$3.65M
derived: sum of 2 quarters · filed 2026-02-26
$4.80M
derived: sum of 3 quarters · filed 2026-02-26
$5.24M
10-K · filed 2026-02-26
2024-09-30$1.03M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$2.18M
derived: sum of 2 quarters · filed 2025-11-06
$2.62M
10-Q · filed 2025-11-06
$2.26M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$1.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
$1.59M
10-Q · filed 2025-08-06
$1.23M
derived: sum of 3 quarters · filed 2026-02-26
-$2.90M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$439.00K
10-Q · filed 2025-05-07
$80.00K
derived: sum of 2 quarters · filed 2026-02-26
-$4.05M
derived: sum of 3 quarters · filed 2026-02-26
-$2.79M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31-$359.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$4.49M
derived: sum of 2 quarters · filed 2026-02-26
-$3.23M
derived: sum of 3 quarters · filed 2026-02-26
-$3.10M
10-K · filed 2026-02-26
2023-09-30-$4.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06
-$2.87M
derived: sum of 2 quarters · filed 2024-11-06
-$2.74M
10-Q · filed 2024-11-06
-$14.68M
derived: sum of 4 quarters · filed 2025-02-26
2023-06-30$1.26M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31
$1.39M
10-Q · filed 2024-07-31
-$10.55M
derived: sum of 3 quarters · filed 2025-02-26
-$12.24M
derived: sum of 4 quarters · filed 2025-02-26
2023-03-31$123.00K
10-Q · filed 2024-05-02
-$11.82M
derived: sum of 2 quarters · filed 2025-02-26
-$13.51M
derived: sum of 3 quarters · filed 2025-02-26
-$13.13M
derived: sum of 4 quarters · filed 2025-02-26
2022-12-31-$11.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26
-$13.63M
derived: sum of 2 quarters · filed 2025-02-26
-$13.26M
derived: sum of 3 quarters · filed 2025-02-26
-$12.48M
10-K · filed 2025-02-26
2022-09-30-$1.69M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
-$1.32M
derived: sum of 2 quarters · filed 2023-11-02
-$538.00K
10-Q · filed 2023-11-02
-$4.83M
derived: sum of 4 quarters · filed 2024-02-22
2022-06-30$375.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03
$1.15M
10-Q · filed 2023-08-03
-$3.14M
derived: sum of 3 quarters · filed 2024-02-22
-$7.91M
derived: sum of 4 quarters · filed 2024-02-22
2022-03-31$779.00K
10-Q · filed 2023-05-04
-$3.52M
derived: sum of 2 quarters · filed 2024-02-22
-$8.28M
derived: sum of 3 quarters · filed 2024-02-22
-$7.86M
derived: sum of 4 quarters · filed 2024-02-22
2021-12-31-$4.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
-$9.06M
derived: sum of 2 quarters · filed 2024-02-22
-$8.64M
derived: sum of 3 quarters · filed 2024-02-22
-$7.91M
10-K · filed 2024-02-22
2021-09-30-$4.76M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
-$4.34M
derived: sum of 2 quarters · filed 2022-11-03
-$3.62M
10-Q · filed 2022-11-03
-$2.90M
derived: sum of 4 quarters · filed 2023-02-23
2021-06-30$419.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
$1.15M
10-Q · filed 2022-08-04
$1.86M
derived: sum of 3 quarters · filed 2023-02-23
$2.57M
derived: sum of 4 quarters · filed 2023-02-23
2021-03-31$728.00K
10-Q · filed 2022-04-29
$1.44M
derived: sum of 2 quarters · filed 2023-02-23
$2.15M
derived: sum of 3 quarters · filed 2023-02-23
$2.85M
derived: sum of 4 quarters · filed 2023-02-23
2020-12-31$714.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
$1.42M
derived: sum of 2 quarters · filed 2023-02-23
$2.12M
derived: sum of 3 quarters · filed 2023-02-23
$2.83M
10-K · filed 2023-02-23
2020-09-30$705.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$1.41M
derived: sum of 2 quarters · filed 2021-11-04
$2.11M
10-Q · filed 2021-11-04
-$12.15M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30$704.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28
$1.41M
10-Q · filed 2021-07-28
-$12.86M
derived: sum of 3 quarters · filed 2022-02-24
-$13.78M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31$705.00K
10-Q · filed 2021-05-04
-$13.56M
derived: sum of 2 quarters · filed 2022-02-24
-$14.49M
derived: sum of 3 quarters · filed 2022-02-24
-$13.47M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31-$14.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
-$15.19M
derived: sum of 2 quarters · filed 2022-02-24
-$14.17M
derived: sum of 3 quarters · filed 2022-02-24
-$13.16M
10-K · filed 2022-02-24
2019-09-30-$923.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$95.00K
derived: sum of 2 quarters · filed 2020-11-05
$1.11M
10-Q · filed 2020-11-05
$1.94M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30$1.02M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31
$2.04M
10-Q · filed 2020-07-31
$2.86M
derived: sum of 3 quarters · filed 2021-02-25
$3.74M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$1.02M
10-Q · filed 2020-04-30
$1.84M
derived: sum of 2 quarters · filed 2021-02-25
$2.72M
derived: sum of 3 quarters · filed 2021-02-25
$3.38M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$822.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$1.70M
derived: sum of 2 quarters · filed 2021-02-25
$2.37M
derived: sum of 3 quarters · filed 2021-02-25
$3.22M
10-K · filed 2021-02-25
2018-09-30$880.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31
$1.54M
derived: sum of 2 quarters · filed 2019-10-31
$2.40M
10-Q · filed 2019-10-31
$3.07M
derived: sum of 4 quarters · filed 2020-02-25
2018-06-30$663.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25
$1.52M
10-Q · filed 2019-07-25
$2.19M
derived: sum of 3 quarters · filed 2020-02-25
$2.95M
derived: sum of 4 quarters · filed 2020-02-25
2018-03-31$854.00K
10-Q · filed 2019-04-30
$1.53M
derived: sum of 2 quarters · filed 2020-02-25
$2.29M
derived: sum of 3 quarters · filed 2020-02-25
$2.88M
derived: sum of 4 quarters · filed 2020-02-25
2017-12-31$673.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$1.44M
derived: sum of 2 quarters · filed 2020-02-25
$2.02M
derived: sum of 3 quarters · filed 2020-02-25
$2.79M
10-K · filed 2020-02-25
2017-09-30$763.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30
$1.35M
derived: sum of 2 quarters · filed 2018-10-30
$2.12M
10-Q · filed 2018-10-30
2017-06-30$588.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01
$1.36M
10-Q · filed 2018-08-01
2017-03-31$769.00K
10-Q · filed 2018-05-02
2016-12-31$565.00K
10-K · filed 2019-02-20
2015-12-31$638.00K
10-K · filed 2018-02-26
2014-12-31-$2.56M
10-K · filed 2017-02-23
2013-12-31$187.00K
10-K · filed 2016-03-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEOGEN CORP (NEOG)United States$2.979B-247.49
Celldex Therapeutics, Inc. (CLDX)United States$2.471B-9.72
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B